These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 28089548

  • 1. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
    Abhyankar MM, Noor Z, Tomai MA, Elvecrog J, Fox CB, Petri WA.
    Vaccine; 2017 Feb 07; 35(6):916-922. PubMed ID: 28089548
    [Abstract] [Full Text] [Related]

  • 2. Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.
    Abhyankar MM, Orr MT, Kinsey R, Sivananthan S, Nafziger AJ, Oakland DN, Young MK, Farr L, Uddin MJ, Leslie JL, Burgess SL, Liang H, De Lima I, Larson E, Guderian JA, Lin S, Kahn A, Ghosh P, Reed S, Tomai MA, Pedersen K, Petri WA, Fox CB.
    Front Immunol; 2021 Feb 07; 12():683157. PubMed ID: 34248966
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques.
    Abhyankar MM, Xu F, Chavez D, Goodroe A, Mendoza E, Chen C, Singh DK, Varnador F, Sivananthan SJ, Kinsey R, Lykins WR, Murphy BM, Martin AR, Tomai MA, Ghosal S, Casper C, Pedersen K, Petri WA, Fox CB.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2374147. PubMed ID: 39090779
    [Abstract] [Full Text] [Related]

  • 4. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.
    Ivory CP, Chadee K.
    Infect Immun; 2007 Oct 31; 75(10):4917-22. PubMed ID: 17620349
    [Abstract] [Full Text] [Related]

  • 5. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis.
    Lotter H, Zhang T, Seydel KB, Stanley SL, Tannich E.
    J Exp Med; 1997 May 19; 185(10):1793-801. PubMed ID: 9151705
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
    Abd Alla MD, Wolf R, White GL, Kosanke SD, Cary D, Verweij JJ, Zhang MJ, Ravdin JI.
    Vaccine; 2012 Apr 26; 30(20):3068-75. PubMed ID: 22406457
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
    Min X, Feng M, Guan Y, Man S, Fu Y, Cheng X, Tachibana H.
    PLoS Negl Trop Dis; 2016 Jan 26; 10(1):e0004419. PubMed ID: 26824828
    [Abstract] [Full Text] [Related]

  • 8. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
    Houpt E, Barroso L, Lockhart L, Wright R, Cramer C, Lyerly D, Petri WA.
    Vaccine; 2004 Jan 26; 22(5-6):611-7. PubMed ID: 14741152
    [Abstract] [Full Text] [Related]

  • 9. Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.
    Guo X, Barroso L, Becker SM, Lyerly DM, Vedvick TS, Reed SG, Petri WA, Houpt ER.
    Infect Immun; 2009 Sep 26; 77(9):3909-18. PubMed ID: 19564375
    [Abstract] [Full Text] [Related]

  • 10. Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.
    Gaucher D, Chadee K.
    Parasite Immunol; 2003 Feb 26; 25(2):55-8. PubMed ID: 12791100
    [Abstract] [Full Text] [Related]

  • 11. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
    Abd Alla MD, White GL, Rogers TB, Cary ME, Carey DW, Ravdin JI.
    Infect Immun; 2007 Aug 26; 75(8):3812-22. PubMed ID: 17526742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Progress towards development of a vaccine for amebiasis.
    Stanley SL.
    Clin Microbiol Rev; 1997 Oct 26; 10(4):637-49. PubMed ID: 9336666
    [Abstract] [Full Text] [Related]

  • 15. CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.
    Guo X, Barroso L, Lyerly DM, Petri WA, Houpt ER.
    Vaccine; 2011 Jan 17; 29(4):772-7. PubMed ID: 21095257
    [Abstract] [Full Text] [Related]

  • 16. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.
    Miller-Sims VC, Petri WA.
    Curr Opin Immunol; 2002 Oct 17; 14(5):549-52. PubMed ID: 12183151
    [Abstract] [Full Text] [Related]

  • 17. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
    Ravdin JI, Shain DC, Kelsall BL.
    Vaccine; 1993 Oct 17; 11(2):241-6. PubMed ID: 8438621
    [Abstract] [Full Text] [Related]

  • 18. Adherence-blocking vaccine for amebiasis.
    Petri WA, Chaudhry O, Haque R, Houpt E.
    Arch Med Res; 2006 Feb 17; 37(2):288-91. PubMed ID: 16380334
    [Abstract] [Full Text] [Related]

  • 19. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.
    Ivory CP, Keller K, Chadee K.
    Infect Immun; 2006 Jan 17; 74(1):528-36. PubMed ID: 16369009
    [Abstract] [Full Text] [Related]

  • 20. Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine.
    Gaucher D, Chadee K.
    Vaccine; 2002 Sep 10; 20(27-28):3244-53. PubMed ID: 12213393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.